Richmond life sciences laboratory product company Grenova has appointed Todd Everline as its new chief financial officer.
The move comes as Grenova continues to grow under the guidance of CEO Lane Major, a co-founder of Leesburg, Virginia, medical implant company K2M who took the lead role with the Richmond company earlier this year.
Everline is also a veteran of K2M, where he previously served as global vice president of finance. In that role, he managed the sales finance and the financial analysis teams and helped lead the company through an IPO. K2M was sold to medical manufacturing company Stryker Corp. in 2018 for $1.4 billion, and Everline played a key role in the integration of those two companies.
He replaces Will Thompson as Grenova's CFO. No reason was given for the change.
Grenova manufactures technology that washes and sterilizes devices used in diagnostic testing, allowing them to be reused rather than thrown away. Grenova said Everline’s financial expertise will be vital in the company’s efforts to drive innovation and profitability while keeping with its core goal of reducing lab waste and enhancing cost savings for its clients.
Everline’s hiring follows recent appointments of Katherine Marrs, a former Stryker exec, as chief commercial officer and Richard Pellegino, a veteran of both K2M and Stryker, as its R&D chief.
Connecticut private equity firm Peloton Equity purchased a majority share in Grenova in 2022 and Major's hiring as CEO followed. He replaced founder Ali Safavi, who kept a seat on the company's board.
